tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GLUE Stock Latest News

Monte Rosa Therapeutics Expands Pipeline with Novartis Deal
Company AnnouncementsMonte Rosa Therapeutics Expands Pipeline with Novartis Deal
14d ago
GLUE
Monte Rosa Therapeutics reports Q3 EPS (29c), consensus (49c)
PremiumThe Fly
Monte Rosa Therapeutics reports Q3 EPS (29c), consensus (49c)
14d ago
GLUE
Boeing to offer 90M common shares, Philips reports mixed Q3: Morning Buzz
PremiumThe Fly
Boeing to offer 90M common shares, Philips reports mixed Q3: Morning Buzz
24d ago
BA
ON
Monte Rosa Therapeutics price target raised to $20 from $16 at Piper Sandler
PremiumThe Fly
Monte Rosa Therapeutics price target raised to $20 from $16 at Piper Sandler
24d ago
NVS
GLUE
Monte Rosa Enters Global License Agreement with Novartis
PremiumCompany Announcements
Monte Rosa Enters Global License Agreement with Novartis
24d ago
8K
GLUE
Monte Rosa announces global license agreement with Novartis
PremiumThe FlyMonte Rosa announces global license agreement with Novartis
24d ago
NVS
GLUE
Monte Rosa Therapeutics presents preclinical data at ENA 2024
Premium
The Fly
Monte Rosa Therapeutics presents preclinical data at ENA 2024
29d ago
GLUE
Monte Rosa Therapeutics announces first participants dosed in MRT-6160 study
Premium
The Fly
Monte Rosa Therapeutics announces first participants dosed in MRT-6160 study
3M ago
GLUE
Monte Rosa Therapeutics price target lowered to $17 from $18 at Wells Fargo
PremiumThe Fly
Monte Rosa Therapeutics price target lowered to $17 from $18 at Wells Fargo
3M ago
GLUE
Monte Rosa Therapeutics sees cash runway into 1H27
PremiumThe Fly
Monte Rosa Therapeutics sees cash runway into 1H27
4M ago
GLUE
Monte Rosa Therapeutics achieves milestones under Roche collaboration agreement
PremiumThe Fly
Monte Rosa Therapeutics achieves milestones under Roche collaboration agreement
4M ago
GLUE
Monte Rosa Therapeutics announces FDA acceptance of IND for MRT-6160
PremiumThe Fly
Monte Rosa Therapeutics announces FDA acceptance of IND for MRT-6160
4M ago
GLUE
Monte Rosa Therapeutics reports Q2 EPS (43c), consensus (54c)
PremiumThe FlyMonte Rosa Therapeutics reports Q2 EPS (43c), consensus (54c)
4M ago
GLUE
These 2 ‘Strong Buy’ Penny Stocks Could Jump at Least 300%, Says Piper Sandler
Premium
Stock Analysis & Ideas
These 2 ‘Strong Buy’ Penny Stocks Could Jump at Least 300%, Says Piper Sandler
5M ago
GLUE
ZURA
Monte Rosa Therapeutics Reports Progress on Drug Development
Premium
Company Announcements
Monte Rosa Therapeutics Reports Progress on Drug Development
5M ago
8K
GLUE
Monte Rosa provides development progress updates on MRT-2359, MRT-6160
PremiumThe Fly
Monte Rosa provides development progress updates on MRT-2359, MRT-6160
5M ago
GLUE
Monte Rosa Therapeutics presents preclinical data on MRT-6160
PremiumThe Fly
Monte Rosa Therapeutics presents preclinical data on MRT-6160
5M ago
GLUE
Monte Rosa Therapeutics Appoints Jennifer Champoux as COO
PremiumCompany Announcements
Monte Rosa Therapeutics Appoints Jennifer Champoux as COO
6M ago
8K
GLUE
Monte Rosa Therapeutics announces leadership team promotions
PremiumThe Fly
Monte Rosa Therapeutics announces leadership team promotions
6M ago
GLUE
Monte Rosa Therapeutics presents data at DDW 2024 on MRT-6160
PremiumThe FlyMonte Rosa Therapeutics presents data at DDW 2024 on MRT-6160
6M ago
GLUE
Monte Rosa Therapeutics 10.6M share Spot Secondary priced at $4.70
Premium
The Fly
Monte Rosa Therapeutics 10.6M share Spot Secondary priced at $4.70
6M ago
GLUE
Monte Rosa prices 10.6M shares at $4.70 in underwritten public offering
Premium
The Fly
Monte Rosa prices 10.6M shares at $4.70 in underwritten public offering
6M ago
GLUE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >